Background: In aesthetic breast augmentation, especially by the transareolar approach, there is increasing concern regarding the occurrence of capsular contracture and its potential correlation with intraoperative implant contamination from putative endogenous breast flora of the nipple and lactiferous ducts. However, detectable bacteria cannot be considered synonymous with established resident microflora. Objectives: The authors sought to elucidate the existence of endogenous breast flora and assess the microbiologic safety of transareolar breast augmentation. Methods: In this prospective study (BREAST-MF), the authors collected microbiologic samples from the breast skin, ductal tissue, and parenchyma of 39 consecutive female patients who underwent breast procedures in a plastic surgery clinic. Swabs collected pre-, intra-, and postoperatively were processed for bacterial and fungal growth. Positive cultures underwent identification through VITEK and MALDI-TOF, as well as antimicrobial susceptibility testing. Results: Staphylococcus species accounted for 95 of 106 (89.6%) positive results from native breast skin, 15 of 18 (83.3%) positive results from decontaminated breast skin, and 4 of 4 (100%) positive results from the breast parenchyma. Methicillin resistance was present in 26.4% of S. epidermidis, 25.3% of S. hominis, and 71.4% of S. haemolyticus strains. Conclusions: During transareolar breast augmentation, in the nipple-areola region it is more likely to find bacteria populating the skin, rather than endogenous breast flora, as previously considered. Appropriate preoperative decontamination is essential for minimizing the risk of postoperative infections.
The incidence of capsular contracture following breast augmentation is a source of increasing concern in aesthetic surgery. One of the factors behind capsule formation is considered to be the intraoperative contamination of the implant. 1, 2 The transareolar approach is considered prone to such contamination, owing to putative endogenous flora of the lactiferous ducts. 1, 3, 4 Because the human body contains 10 times more bacterial cells than human cells, 5, 6 the identification of bacterial species should be expected when sampling virtually any compartment of the body, including the breast. However, the isolation of bacteria from an anatomic site is not synonymous with the existence of established local microflora. For bacterial communities to qualify as resident flora, the following 4 criteria must be met simultaneously: (1) The species identified are different from those of surrounding areas; (2) the habitat is rich in nutrients, enabling bacteria to survive and shielding them from the host's local antiinfective protection; (3) the species isolated are nonpathogenic and consistently identified over a relatively large sample of subjects; and (4) the microorganisms perform a role in that anatomic area. 7 To elucidate the controversy regarding the existence of endogenous breast flora, 8 we conducted a prospective study (BREAST-MF) to identify and characterize the microbial species present on the breast skin, ductal tissue, and parenchyma.
METHODS
The methodology of the prospective study BREAST-MF has been described previously. 7 Microbiologic samples were systematically collected from 39 consecutive female patients who underwent breast surgery in the ProEstetica Medical Center (Bucharest, Romania) from February 2013 to September 2013. All patients signed a study-specific informed consent document endorsed by the Institutional Review Boards of the National Institute for Infectious Diseases "Prof. Dr Matei Bals" and the ProEstetica Medical Center prior to any study procedures. The study was conducted in line with the principles of Good Clinical Practice (ICH GCP).
Thirty minutes before the initial incision, patients received a single dose of cefuroxime intravenously (1.5 g). The skin was prepared successively with 70% ethanol (Scandic Distilleries, Romania) and a solution of iodine tincture (50 mL) in 70% ethanol (50 mL). The skin was then draped in the standard manner. The surgical technique aimed to minimize implant contamination, tissue trauma, and bleeding, as these factors are implicated in the etiology of capsular contracture. The implant pocket was washed intraoperatively with a double antibiotic irrigation solution (750 mg cefuroxime and 80 mg gentamicin in 100 mL saline) without active suctioning. Patients were monitored for a minimum of 2 years postoperatively. Results are currently available for 1 year of follow-up in all patients.
Microbiologic samples collected pre-, intra-, and postoperatively ( Figure 1 ) with culture swabs (Copan Diagnostics Inc, Murrieta, CA, USA) were processed for aerobic bacterial and fungal growth on Columbia agar with 5% sheep blood, cystine lactose electrolyte-deficient agar, and Sabouraud gentamicin chloramphenicol 2 agar (all Biomérieux, Marcy-l'Étoile, France). After 24 to 48 hours of incubation at 35±2°C, positive cultures were submitted to microbial identification through Vitek (Biomérieux) and matrix-assisted laser desorption/ionization time-of-flight MALDI-TOF (Bruker, Germany) at the National Institute for Infectious Diseases "Prof. Dr Matei Balș " (Bucharest, Romania).
Patient characteristics, as well as previous exposures to the healthcare system and to antimicrobial treatments were quantified for each study subject by means of the Carmeli score, which enables infectious disease practitioners to evaluate the preliminary risk of antimicrobial resistance of pathogens. 9 The score is computed from data regarding the patient's immune status, comorbidities, history of antibiotic treatment, and types of contact with the healthcare system during the preceding 6 months. A Carmeli score of 1 is suggestive for a lack of expected antimicrobial resistance, 2 indicates potential resistance in Gram-negative bacilli, and 3 suggests a potential for extreme drug resistance. A history of previous breast intervention in the absence of other risk factors was considered a Carmeli score of 2 regardless of the duration since the intervention.
Statistical analysis was performed with SPSS Statistics for Windows (version 22.0, IBM Corp, Armonk, NY). The normality of data distribution was assessed with the ShapiroWilk test, and the z test was applied to ascertain the significance of differences between proportions. Statistical significance was defined as P < 0.05.
Of 39 female patients in this study who underwent breast surgery, 32 (82.1%) presented to the ProEstetica Medical Center for aesthetic surgery, and 7 (17.9%) presented for oncologic surgery. The aesthetic surgery group included 26 patients who underwent bilateral breast augmentation and 6 patients who underwent bilateral mammaplasty ( Table 1 ). The oncologic surgery group included 5 patients who underwent unilateral mastectomy and 2 patients who underwent unilateral sectorectomy.
RESULTS

Patient Characteristics
The median age and standard deviation for the study population were 36.0±11.7 years, and the mean age was 38 years (range, 25-75 years; Table 2 ). Twenty-three of 39 subjects (59%) had not undergone breast surgery previously. Of 32 women presenting for aesthetic surgery, the reason for the current intervention was primarily aesthetic, with only 2 patients (6.3%) presenting for reintervention following rupture of the previous implant. Patients presenting for aesthetic surgery were significantly younger (P = 0.018) and more likely to be current smokers (P = 0.010) than patients who presented for oncologic surgery (Table 2) . Of 39 patients, a Carmeli score of 1 was computed for 11 patients (28.2%), while 17 patients (43.6%) had a score of 2, and 11 patients (28.2%) had a score of 3.
Microbial Flora of the Breast
Native Breast Skin
Of 106 identifications of flora on native skin, 95 (89.6%) corresponded to staphylococci, with Micrococcus luteus, Leuconostoc mesenteroides, and other microorganisms populating the skin less frequently (Figure 2 ). Among the strains of Staphylococcus that were identified on native skin, S. epidermidis and S. hominis were most prevalent, accounting for 46 (48.4%) and 35 (36.8%) of the 95 strains identified, respectively ( Figure 3 ). S. lugdunensis accounted for 5 microbial identifications (5.3%), S. haemolyticus and S. capitis each accounted for 3 identifications (3.2%), and S. aureus, S. auricularis, S. cohnii, and S. warneri each accounted for 1 identification (1.1%). 
Decontaminated Breast Skin
Areolar Incision (Ductal Tissue)
Two of 64 swabs from the ductal tissue (3.1%) yielded positive bacterial growth, in 2 patients from the aesthetic surgery group. The results of further testing identified these bacteria as S. hominis and S. lugdunensis. The patient with detectable S. hominis in the ductal tissue had periareolar folliculitis in the contralateral breast for which S. hominis was the etiologic agent. The patient with detectable S. lugdunensis in the ductal tissue also had this species on her native skin before preoperative decontamination. The bacterial load determined by the number of colony-forming units (CFUs) associated with these positive identifications was roughly 1000-fold lower than that of microorganisms cultured from swabs of native skin from the same subject and 30-fold lower than that of decontaminated skin (data not included). In addition, culture positivity was not associated with early or late stage postoperative infection. The procedure to manage mammary asymmetry involved transareolar subpectoral augmentation of the right breast and transareolar subpectoral augmentation with vertical mastopexy of the left breast.
Breast Parenchyma
Four of 66 samples collected from the breast parenchyma at medium depth (6.1% of all swabs collected from this region) were positive for staphylococcal growth, including 1 from a patient who underwent oncologic surgery and 3 from aesthetic surgery patients. These positive results corresponded to bacterial loads roughly 300-fold lower than those of native skin and 4-fold lower than those of decontaminated skin. For the oncologic surgery patient, S. epidermidis had also been identified on the ipsilateral native inframammary fold, the nipple-areola area, and on the decontaminated axillary skin. Of 3 aesthetic surgery patients, 1 had S. hominis in the ipsilateral nipple-areola area before and after decontamination, 1 had S. capitis on the ipsilateral native axillary skin, and 1 had staphylococcal colonization with high bacterial loads in both breasts despite S. lugdunensis being absent from previous culture identifications of that patient. Of 67 samples collected from the deep breast parenchyma, only 1 (1.5%) yielded bacterial growth. This positive result was identified as S. epidermidis and was obtained from a patient presenting for oncologic surgery who previously had positive results for this species on her ipsilateral decontaminated nipple-areola area. The bacterial load from this swab was roughly 1000-fold lower than that of native skin and 10-fold lower than that of decontaminated skin. The results of all 59 swabs from the axillary parenchyma were negative.
When applicable, swab sampling was conducted to assess colonization of intracapsular fluid. In this compartment, no bacterial or fungal growth was detected from the 18 swabs collected. Twenty samples were obtained from capsules during secondary augmentation for preexisting capsular contracture, and implants were sonicated to observe the presence of biofilms. 7 None of the 20 samples yielded bacterial growth, supporting a chronic inflammatory (foreign body) reaction, rather than an infection, as the underlying etiology of capsular contracture. Sonication results are not included in the present report due to logistic reasons.
No postoperative infections occurred in the study subjects, regardless of swab culture results. During 1 year of follow-up, no patients developed capsular contracture, regardless of intraoperative swab status.
Sealed Nipple
Swabs of the sealed nipple after the surgical procedure yielded bacterial growth in 4 patients (5 of 54 swabs, 9.3%). The 5 positive results corresponded to 4 identifications of S. epidermidis and 1 identification of S. hominis; these Staphylococcus species had also been isolated from the corresponding patients' native skin. Swab positivity was not associated with a different postoperative clinical evolution. Because our study was not designed to evaluate the efficacy of nipple shields, we cannot provide recommendations regarding their utility in surgical practice.
Antimicrobial Susceptibility Patterns
We identified a relatively low prevalence of methicillin resistance among coagulase-negative staphylococci (CoNS) isolated in this study. Specifically, methicillin resistance was identified in 19 of 72 (26.4%) S. epidermidis strains, 19 of 75 (25.3%) S. hominis strains, 5 of 7 (71.4%) S. haemolyticus strains, and 0 of 10 S. lugdunensis, 6 S. capitis, 1 S. warneri, 1 S. auricularis, and 1 S. cohnii strains. Statistically significant differences in methicillin resistance were observed between the 2 patient groups with respect to S. hominis. A 60% resistance prevalence was observed among patients presenting for oncologic surgery compared with a 20% prevalence among aesthetic surgery patients (P = 0.007). In contrast, S. epidermidis had a 30% resistance prevalence among patients in the oncologic surgery group and a 25.8% resistance prevalence in the aesthetic surgery group (P = 0.779). Statistically significant differences were identified for methicillin resistance vs Carmeli score, but not for primary vs nonprimary breast interventions (Table 3) .
DISCUSSION
Staphylococcus species are recognized components of the human microbiota, ranking second in skin flora (mostly CoNS) after Propionibacterineae 10 and third in the nasal cavity (mostly S. aureus) 11, 12 after Propionibacterineae and Corynebacterineae. 10 Methicillin resistance has been well studied in S. aureus strains, with prevalences ranging from 0.9% to 12% 11 in colonization and 62% 13 in infection. However, there is less information regarding methicillin resistance in CoNS, with an estimated prevalence of 20% 14 to 62% 15 in colonization and up to 46% 13 to 84% 16 in infection.
In the present study, methicillin resistance was fairly low in CoNS with the exception of S. haemolyticus, an important finding, as CoNS are thought to harbor resistance determinants transferable to S. aureus, such as the staphylococcal cassette chromosome mec. 17 Although classically applied for evaluating infections with Gram-negative bacilli, 9 we found that the Carmeli score is also applicable for computing methicillin resistance in Gram-positive cocci.
An aim of this study was to identify the microbial species present on the breast skin and parenchyma and to establish whether these constitute a specific resident flora of the breast. The results of our study indicated that the primary criterion for defining resident flora, that "the species identified are different from those of the surrounding areas," 7 was not met. Instead, the species we identified on and inside the breast are notoriously present on all skin areas of the body and are nonspecific for the breast area. We were unable to identify a specific microbial flora of the breast, other than the expected local skin flora. Although our study was not designed to assess the efficacy of preoperative decontamination, we did identify bacteria on the skin after decontamination and before the first incision. The CFU count was lower on decontaminated skin than on native skin (data not included) and positive results were not associated with postoperative infection. Therefore, our findings suggest that the breast should be considered a clean surgical site, rather than a clean-contaminated site, when elective procedures are performed in immunocompetent patients (ie, Carmeli 1), especially because no tracts known to harbor microbial flora are entered during the procedure (eg, the respiratory, gastrointestinal, or genitourinary tracts).
Current guidelines for prophylaxis in aesthetic breast surgery indicate that for clean breast procedures in patients without risk factors for infection, no antibiotics should be administered. 18 In the presence of risk factors, a single dose of intravenous cephalosporin may be administered preoperatively. 18, 19 These indications are consistent with the results of our study because cephalosporins are effective against the strains we identified on the breast skin, including methicillin-susceptible S. aureus and CoNS. Therefore, switching from cephalosporins to oxacillin would not be needed based on the bacterial isolates identified in this report. However, oxacillin could be an appropriate replacement for cephalosporins because it has a narrower antibacterial spectrum and could reduce the selective pressure leading to resistance in the microbiome. 9 This replacement could only be attempted for a subset of patients, who lack comorbidities and have a Carmeli score of 1. Because the present study was not designed to evaluate the impact of preoperative antimicrobial prophylaxis on the human microbiome, we cannot provide any definite recommendations without performing further work on this topic.
The present study had a number of limitations. This study was designed to be observational and did not enable a comparison of surgical approaches. Therefore, our study can only describe the bacterial flora identified during transareolar breast procedures, without drawing conclusions regarding other surgical approaches. In addition, this study involved a relatively small sample size, not surprising given that the isolation of microorganisms residing within the breast can only be performed in patients undergoing surgery, rather than the general population. However, our study group was similar in size to those of other studies addressing intraoperative sampling of microorganisms.
1,20
CONCLUSIONS
During transareolar breast augmentation, we occasionally encountered bacterial populations in the nipple-areola region that were consistent with those of the skin surface. Our findings do not support the existence of specific resident microorganisms of the breast, as previously suggested. Appropriate preoperative decontamination is essential for minimizing the risk of postoperative infections. If antibiotic prophylaxis is administered before breast surgery, the antimicrobial agent should display activity against staphylococci because these types of microorganism were identified most frequently.
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